Fractyl Health says procedure can maintain weight loss after stopping GLP-1

Fractyl Health (GUTS) said that data from an open-label study of its Revita outpatient endoscopic procedure helped patients who had stopped taking a GLP-1 medication maintain the weight they had lost. The REVEAL-1 Cohort enrolled patients who had lost at least 15% of their body weight while on a GLP-1.

https://seekingalpha.com/news/4527756-fractyl-health-says-procedure-can-maintain-weight-loss-after-stopping-glp-1